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Microarray embedding/Sectioning 
for Parallel Analysis of 3D Cell 
Spheroids
Jonathan Gabriel1, David Brennan2, Jennifer H. Elisseeff3 & Vince Beachley  2*
Three-dimensional cell spheroid models can be used to predict the effect of drugs and therapeutics 
and to model tissue development and regeneration. The utility of these models is enhanced by high 
throughput 3D spheroid culture technologies allowing researchers to efficiently culture numerous 
spheroids under varied experimental conditions. Detailed analysis of high throughput spheroid 
culture is much less efficient and generally limited to narrow outputs, such as metabolic viability. We 
describe a microarray approach that makes traditional histological embedding/sectioning/staining 
feasible for large 3D cell spheroid sample sets. Detailed methodology to apply this technology is 
provided. Analysis of the technique validates the potential for efficient histological analysis of up to 96 
spheroids in parallel. By integrating high throughput 3D spheroid culture technologies with advanced 
immunohistochemical techniques, this approach will allow researchers to efficiently probe expression of 
multiple biomarkers with spatial localization within 3D structures. Quantitative comparison of staining 
will have improved inter- and intra-experimental reproducibility as multiple samples are collectively 
processed, stained, and imaged on a single slide.
Biological systems are extremely complex and are not well represented by conventional two-dimensional cell 
monolayer culture models. Cells cultured in monolayer adopt a flat/spread morphology with a majority of cel-
lular attachment points to flat substrates on the basal surface of each cell. In this configuration, the diffusion 
of nutrients and drugs is unrestricted at the apical surface and limited at the basal surface. Cell-cell adherence 
junctions occur only at the perimeter of morphologically flat cells. These conditions are far from representative of 
a cell’s normal in vivo microenvironment, a three-dimensional arrangement allowing for numerous cell contacts 
linked by vascular structures and extracellular matrix, promoting the diffusion of oxygen, nutrients, metabolites, 
hormones, growth factors and cytokines between cells comprising solid tissues, and tumors alike (Fig. 1A,B). 
Alternatively, cells may be cultured in three-dimensional aggregates using methods such as hanging drop cell 
spheroid culture to mimic the physiology of in vivo systems on a microscale level1,2. Cells in three-dimensional 
configurations adopt the proper shape, experience cell-cell contacts and nutrient diffusion in all directions, and 
more closely represent the natural microenvironment of tissues and tumors. Nutrient exchange occurs through 
adjacent cell layers in all planes. Variance in outcomes due to cell culture conditions can be confirmed by measur-
ing drug response characteristics of identical cells cultured in 2D vs. 3D culture systems3–5. Thus, 3D cell culture 
models are important for (1) accurately modeling mechanisms of normal physiological processes, tumor biology 
and tissue regeneration, and (2) for screening and assessing new treatments6,7.
The potential of 3D culture has been recognized by the research community with increased prevalence in 
journal publications and with the development of many products that facilitate high throughput 3D spheroid 
culture8–10. However, the versatility of these culture systems is limited due to lack of methods of high through-
put immunohistochemical biomarker analysis11. Histological and immunohistochemical staining identifies and 
quantifies specific biomarker expression in cellular studies and is easily integrated into arrays of two-dimensional 
cultures of 96 samples and larger. However, such analysis of 3D cultures requires deep confocal imaging or sec-
tioning and staining of individual samples12. Both methods yield valuable biological information, including spa-
tial position within 3D spheroids, but they are inefficient and research costs may be prohibitively high. High 
throughput 3D in vitro models must be compatible with efficient histological and immunohistochemical analysis 
to realize their potential.
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This manuscript describes a straightforward, low-cost microarray technology that improves the efficiency 
of sectioning/staining/analyzing 3D spheroids. Previously, this method was effectively used to analyze adipose 
derived stem cell (ASC) response to decellularized tissue particles13. The goals of this manuscript are to bench-
mark performance of the technique, optimize methodologies and to describe the method in careful detail to ena-
ble replication and further refinement in other laboratories. Fixed 3D spheroids are arranged in the same plane 
using a microarray of wells stabilized by an agarose gel matrix for paraffin embedding and sectioning (Fig. 1F). In 
principle, the methods described share many similarities with tissue microarray (TMA) coring methods currently 
used to convert tissue biopsy samples into arrays for analysis. TMA coring methods have revolutionized the field 
of pathology by increasing efficiency and throughput14. Traditional microarray procedures use a coring machine 
to take cylindrical cores as small as 600 μm in diameter, and a few millimeters in length, from paraffin embedded 
tissue samples. The samples are manually transferred to a paraffin recipient block in a microarray arrangement 
(Fig. 1E). While this method is not technically impossible for in vitro 3D spheroids, their small size makes it 
extremely difficult to arrange them in the same cutting plane for parallel analysis. Furthermore, traditional TMA 
requires specialized coring equipment and trained operators. The approaches described within utilize simple 
equipment allowing for spheroid microarray arrangement under aqueous conditions. Up to 96 spheroids were 
precisely arranged in a single microarray in the same cutting plane for efficient processing and analysis.
Methods
Microarray negative mold fabrication. A negative mold was fabricated to confine spheroids in a 
microarray pattern. These negative molds can be infiltrated with agarose to make sectionable spheroid microar-
ray paraffin blocks. The negative mold can be made from plastic or polydimethylsiloxane (PDMS). To fabricate 
the PDMS negative mold, a patterned positive array, which we will call the “pre-mold” was required to produce 
the final PDMS negative mold. Two approaches for the “pre-mold” were tested: (1) aluminum pre-mold: machined 
from a solid block of aluminum using a computer numerical control machine (CNC) and (2) agarose pre-mold: 
agarose solution was cast in a nylon template. The nylon template was machined using a lathe and drill press.
Aluminum pre-mold approach (PDMS). A positive, aluminum mold was designed in SolidWorks™ (file availa-
ble, Supplemental Methods S.15) and machined using a 5°, 1/32” tapered end mill (Ford) via a Computer Numeric 
Control (CNC) process (Fig. 2). An end mill with 5° tapers was selected to provide relief during mold release. 
Posts were made as close as possible within machining limits. For example, final dimensions of a typical alumi-
num mold were 1.5 mm diameter × 1.5 mm tall posts with a center to center spacing of 2.39 mm between posts 
in the array. The aluminum part was used along with the Slygard® 184 Silicone Elastomer Kit (base-to-curing 
agent ratio of 7:1) to create a PDMS negative mold. The silicone mixture was poured over the positive aluminum 
Figure 1. Schematics show (A) Perimeter cell-cell contacts and single surface diffusion in 2D. (B) Global 
cell-cell contacts and global diffusion through surrounding cells in 3D. (C) The gross appearance of a 3D cell 
spheroid (live cells stained with calcein-AM) is similar in shape and size to (D) structures that make up an in 
vivo breast cancer tumor growing in a mouse23. (E) Traditional tissue microarray (TMA) uses an array coring 
device to remove and arrange tissue cores from paraffin embedded tissue samples in a paraffin recipient block. 
(F) The spheroid microarray is arranged in aqueous conditions and stabilized in agarose. The entire microarray 
and mounting cassette are infiltrated with paraffin to enable sectioning.
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mold into a 125 mm petri dish and allowed to cure under vacuum at 65 °C for a period of 24 hours to create the 
final PDMS negative mold. Microarrays generated with this approach were used for analysis presented in this 
manuscript. 
Agarose pre-mold approach (PDMS). The agarose pre-mold approach involves machining a nylon (or other 
plastic) template that is used to cast a sacrificial agarose pre-mold (Fig. 2). The negative template is machined 
from plastic rod using a lathe and drill press. For example, a nylon cylindrical rod of diameter 50 mm was cut to a 
height of ~7 mm, creating a short, wide cylinder (disk). A single hole of 30 mm diameter was lathed to a depth of 
5 mm concentrically into the flat edge of the nylon cylinder, thus creating a nylon cup. Through holes with diam-
eters of 1.5 mm were drilled in a microarray pattern into the base of the inner cupped surface using a drill press. 
The array was created with a spacing of 1.75 mm between the center of each hole in the array; hole depths 2 mm 
each. This method allows for closer-packing of the holes of the microarray compared to the aluminum pre-mold 
approach. A thin PDMS film was pressed to the bottom of the template and taped down to water seal the through 
holes. Then it was filled with 3% wt/v agarose solution to create an agarose pre-mold. The pre-mold is fabricated 
using the microjetting protocol described in detail in Figure 3 to ensure removal of air bubbles. Care must be 
taken to ensure that the base of the agarose pre-mold is completely flat and parallel to the face of the microarray 
pillars. After curing at room temperature, the positive agarose pre-mold was placed in a 125 mm petri dish and 
covered with PDMS (Slygard, 7:1 base-to-curing agent) and allowed to cure under vacuum at 60 °C for 2 days. 
The positive agarose pre-mold was broken up and removed from the PDMS mold with small tools and pressured 
water leaving a PDMS negative mold containing a microarray of wells.
Sealed plastic-mold approach. A third approach can be used to make an agarose spheroid microarray using the 
plastic template as the negative mold (Supplemental Video 2). A plastic mold with through holes, fabricated and 
sealed as described above, can be directly used as the negative mold according to methods described in Figure 3.
Spheroid microarray fabrication and processing. The negative microarray mold was filled with deion-
ized water (Fig. 3A,B). Microbubbles were removed using a 1 mL pipette and the following microjetting technique 
(Fig. 3A). A pipette was depressed before its tip was submerged into the water above the microwells. The push 
button was then released, and repeatedly depressed and released through small arcs of motion sending microjets 
of water (~100 µL each) at submerged microbubbles trapped in the array resulting in bubble ejection. Removal of 
all microbubbles is imperative for successful microarray fabrication. Alternatively, microbubbles may be removed 
via centrifugation of a water filled mold for 5 minutes at 1500 rpm with a high degree of efficacy.
Cell spheroids (cultured as described in the Supplemental Methods S.1 & S.2) were then placed individually 
into microwells using a 1 mL pipette and a gravitational transfer technique. First the pipette tip was trimmed at a 
45° angle approximately 2–3 mm from its distal end to allow for the passage of ~500 µm spheroids. Spheroids were 
pipetted up from the 96 well GravityTRAP™ plate and then the pipette tip was submerged above the desired well 
in the PDMS negative microarray and held stationary in a vertical orientation, without depressing the plunger. 
This allowed the spheroid to fall out of the modified pipette tip into the appropriate well of the microarray using 
gravity alone (Fig. 3B). Arrays of 24- (4 × 6) and 96-spheroids (8 × 12) were created using the 96-well PDMS 
Figure 2. Negative mold fabrication by three alternative methods: (1) Aluminum pre-mold is machined from 
a solid block of aluminum and immersed in PDMS within a petri dish then removed leaving a PDMS negative 
mold. (2) Agarose pre-mold is cast in a plastic template, where the template is machined from a rod using a 
lathe and drill press. The plastic template is filled with agarose solution that is cured to form a hydrogel that 
is removed and immersed in PDMS within a petri dish. After the PDMS is cured the agarose gel is removed 
leaving a PDMS negative mold. (3) A plastic mold can be used directly as the negative mold when the through 
holes are sealed by pressing a PDMS film over the bottom of the mold and securing with tape (Supplemental 
Video 2).
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mold. Arrays of 24-spheroids were created using the central wells of the 96-well mold. Spheroid placement was 
performed using visual inspection and verified using inverted light microscopy (Carl Zeiss Axio Vert.A1).
After the removal of excess water above the top level of the wells (Fig. 3C), verified arrays were infiltrated with 
agarose (Fig. 3D). UltraPure™ agarose (Invitrogen, 16500500) was added to deionized water at 3% (wt/v) and 
boiled until homogenous. Agarose concentration was selected based on experiments described in Supplemental 
Methods S.4. Agarose solution was cooled to 80 °C and used to infiltrate the assembled microarray by pipetting at 
a rate of approximately 0.1 mL/sec into the corner of the mold (Fig. 3D). Agarose was added until a slight menis-
cus was formed above the height of the open mold. A tissue cassette (Symport) was then mounted as shown in 
Fig. 3E and additional agarose was added to the top of the cassette so that agarose would surround cassette on the 
basal and apical surfaces, fixing the cassette to the agarose microarray solidly. The infiltrated mold and cassette 
were placed in the oven at 65 °C for 5 minutes to reduce the rate of cooling/curing, while promoting mixing of 
agarose into the bottom of each well. The microarray assembly was then removed and cooled at room tempera-
ture for 45 minutes. The completed microarray was carefully removed from the mold by peeling and pulling on 
the cassette, which was tightly adhered to the agarose microarray (video of preceding procedures available in 
Supplemental Video 1). The agarose microarray was dehydrated and infiltrated on a mechanical shaker, medium 
speed, at 37 °C using the following series of 100 mL solution washes (# of washes X duration) in urine specimen 
containers (Starplex Leakbuster, 120 mL): 50% ethanol (1 × 3 hr.), 70% ethanol (1 × 3 hr.), 85% ethanol (1 × 3 hr.). 
95% ethanol (1 × 3 hr.), 100% ethanol (3 × 3 hr. + 1 overnight), HistoClear II (National Diagnostics, 3 × 3 hr.), 
molten paraffin wax (Fisher Histoplast LP, 5 × 3 hr. at 60 °C). Fluid mixing could be observed at the periphery of 
the microarray by holding the specimen jar to the light and shaking. Incompletely mixed solutions could be vis-
ualized by the refraction of light by fluid boundary layers near micropillars when disturbed. Such solutions were 
thoroughly shaken by hand and then allowed an additional hour for mixing on the shaker before being advanced 
to the next wash. A series of images following one spheroid microarray through the embedding & sectioning 
procedures is shown in Fig. 3G. Analysis of sections taken from this microarray (Fig. 3G) were used to efficiently 
investigate the effect of decellularized extracellular matrix particles on adipose derived stem cell differentiation in 
a previous study of 80 spheroid samples13.
Figure 3. Agarose microarray fabrication (with spheroids). (A) Microjetting bubble removal technique. 
(B) Spheroid gravitational transfer technique. (C) Water removal. (D) Agarose infiltration/mixing. (E) Final 
cassette position on PDMS negative mold. (F) 96 spheroids embedded in 12 × 8 agarose microarray attached to 
sectioning cassette from side view. Spheroids appear to be in the same sectioning plane (white dotted line) and 
parallel to the cassette base. As a frame of reference, a yellow dotted line shows spheroid offset in the z direction 
that would occur with a 2° misalignment of the agarose microarray to the cutting plane. (G) Images of a single 
block going through the sequential process starting with spheroid microarray pattered in water (step B above) 
through a stained paraffin section (large tissue fragments are placed in two wells instead of spheroids for easy 
identification of microarray orientation). Video available in Supplemental Video 1.
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Microtome alignment & histological processing. Paraffin infiltrated agarose spheroid microarrays 
were mounted in a microtome with three axis of freedom. In order to obtain sections containing the maximum 
number of spheroids the optimal cutting plane is parallel to the common plane of the spheroid microarray. A 
procedure described in Supplemental Methods S.5 (Supplemental Video 3) was used to align the cutting plane 
to the top face of the paraffin block. The angular deviation between the cutting plane and the common plane of 
the spheroid microarray is referred to as tilt (θt in Fig. 4A). The critical tilt angle at which all of the spheroids in 
a microarray could not be obtained on the same slide was estimated using a geometrical calculation described 
in Supplemental Methods S.6–8. The experimental tilt in practice that was associated with the described proce-
dures was determined by observing the appearance of agarose pillars from different regions of a microarray on 
consecutive sections (Supplemental Methods S.9). All specimens were taken in 20 µm or 7.5 µm sections, stained 
using routine H&E with bluing agent (VWR Bluing Agent RTU), and mounted using Fluoro-Gel with TES Buffer 
(Electron Microscopy Sciences). The effect of processing on spheroid size due to swelling and contraction was 
quantified as described in Supplemental Methods S.10.
Quantification of system efficacy. Four independent microarray blocks (n = 4) each containing 
24-spheroids were analyzed to determine the quality, quantity and reproducibility of spheroid transfer to histo-
logical slides and the effects of processing. The number of spheroids in the array that were successfully transferred 
to histological sections was quantified using 25% of maximum possible spheroid cross-sectional area as a thresh-
old (Supplemental Methods S.11).
Results
theoretical tilt analysis. Figure 4A shows a visual estimation of where spheroids would be cross-sectioned 
based on their distance from the center of the array and the angle of tilt. This schematic analysis assumes that all sphe-
roids in the microarray are in the same plane with a spacing of 2.39 mm between each ~500 µm diameter spheroid. 
The virtual sectioning plane shown in Fig. 4A is from the perspective of the xz plane (defined in Figs 3G and 4D). 
Three virtual angles of tilt (Θtx = 0, 0.5 & 1°) and three different spheroid microarray sizes (6 × 4, 8 × 6 & 12 × 8) 
are included in the schematic. The estimated spheroid cross-sections on a resultant histological section are vis-
ualized in Fig. 4B with a dotted line representing the spheroid cross-section at an ideal 0° tilt angle. This anal-
ysis clearly shows the important inverse relationship between tilt angle and spheroid cross-sectional area on a 
histological section and the inverse relationship between array size and cross-sectional area of the outermost 
Figure 4. Tilt during sectioning and the relationship of spheroid area on histological sections vs. angle of tilt. 
(A) Schematic model showing the predicted cutting plane through a row of 12 spheroids at three different 
angles of tilt &#x03F4;t = 0, 0.5 & 1°. View is in the xz plane where the y-axis goes through the center of each 
spheroid in the row. (B) The estimated view of the cross-section of the row of spheroids (from A) as they would 
show up on a histological section. The color dotted lines correspond to an “ideal” cross-section through the 
center of each spheroid. Schematics are shown for 6 × 4, 8 × 6 & 12 × 8 arrays at angles of &#x03F4;t = 0, 0.5 & 
1°. (C) A geometrical calculation predicts the critical angle when the outmost spheroid in an area is completely 
absent from the centerpoint section. (D) The coordinate system and angles of tilt in the xz (&#x03F4;tx)and yx 
(&#x03F4;ty) planes are show against an agarose microarray. (E-top) A schematic of five sequential sections 
(A–E) taken from an agarose microarray paraffin embedded block as viewed from the xz plane. (E-bottom) The 
corresponding row of pillars appearing on 5 consecutive histological sections used to calculate the experimental 
tilt for the agarose microarray system.
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spheroid in the array. The critical tilt angle where the outermost spheroid is completely missed in a perfect array 
of 50–1000 µm diameter spheroids is plotted in Fig. 4C (sample calculation shown in Supplemental Methods S.7). 
Three different size arrays (12 × 8, 8 × 6 & 6 × 4) and two different spacings between spheroids (2.39 mm & 
1.75 mm) are plotted. The larger spacing is associated with the aluminum pre-mold method and the smaller 
spacing is associated with the agarose pre-mold method. The critical angle of tilt varies from 6.51° for 1000 µm 
spheroids in a compact array to 0.109° for 50 µm spheroids in a wider array. To keep the percentage of outer sphe-
roid area section cross-sectional area to >90% of maximum possible, the critical angle in Fig. 4C for a spheroid 
of ~25% diameter of the spheroid of interest could be used as a rough estimate. For example, the critical angle 
for a 125 µm spheroid in a 12 × 8 array with 2.39 mm spacing is 0.272°. A 125 µm spheroid diameter is 25% as 
large as a 500 µm diameter so one could estimate that the outer spheroid in a 12 × 8 array with 500 um spheroids 
and 2.39 mm spacing would have >90% of the maximum possible cross-sectional area on a centered histological 
section for a tilt angle of 0.272° (sample calculation shown in Supplemental Methods S.8).
Experimental tilt analysis. Figure 4D,E shows how the tilt value is experimentally related to the number of 
agarose pillars occurring in consecutive sections. In Fig. 4E, A, B, C, D & E represent a single row of agarose pillars 
showing up on consecutive histological sections. As subsequent sections are taken, the number of agarose pillars on 
the section changes due to the depth of the cut and the angle of tilt. The number of agarose pillars on consecutive sec-
tions were counted to determine experimental tilt associated with the method (Supplemental Methods S.9) Average 
tilt along the x-axis (θtx) was determined to be 0.115°, correlating to a predicted <2% cross-sectional area lost for 
the outermost spheroid in a 12 × 8 microarray of 500 µm spheroids. Tilt along the y-axis (θty) was slightly greater 
at 0.154° corresponding to a predicted <1% area lost for the outermost spheroid in a 12 × 8 microarray of 500 µm 
spheroids. These results indicate that spheroid microarray fabrication, mounting and sectioning methods allowed 
for very accurate alignment of the plane of the agarose microarray to the sectioning plane (xy).
Processing effects. Spheroids are subject to dehydration and elevated temperatures during processing. 
Swelling or shrinking of spheroids during processing could affect subsequent sectioning and analysis so these 
effects were quantified. For a 40 spheroid sample set, the pre-processing maximum spheroid cross-sectional 
area, measured in PBS after paraformaldehyde fixation, was 1.728 × 105 µm2 (σ = 2.270 × 104, n = 40) and the 
post-processing maximum cross-sectional area, measured on unstained histological sections, was 1.312 × 105 
µm2 (σ = 7.021 × 103, n = 37). This indicates an average 24.1% reduction in spheroid cross-sectional area and a 
13.0% reduction in spheroid diameter associated with dehydration and embedding processing effects. Student’s 
t-test indicated that this result was statistically significant (p = 1.594 × 10–9 < 0.001).
Efficiency of spheroid microarray histological processing. Spheroid microarray histology will be 
most powerful when the maximum number of spheroids appear on a single section for parallel analysis and when 
a maximum number of these ideal sections can be captured for staining for different markers on multiple slides. 
Thus, two important metrics associated with sectioning were analyzed: (1) total number of histological sections 
that each individual spheroid appears in within a series of consecutive sections and (2) number of different sphe-
roids appearing on a single section for parallel analysis.
Individual spheroid series. An image of a spheroid is shown in PBS after paraformaldehyde fixation, but before aga-
rose and paraffin processing and embedding (Fig. 5A ~250 µm diameter) and after sectioning, but prior to rehydration 
and staining (Fig. 5B). The theoretical number of sections that can be taken from this spheroid and the cross-sectional 
area appearing on each section can be estimated using the spheroid diameter and the section thickness (Fig. 5C). The 
cross-sections of this single spheroid followed over a series of eleven consecutive sections are shown together in Fig. 5D 
(selected zoomed in images shown in Supplemental Methods S.12). The thickness of each section was 20 μm. Therefore, 
eleven consecutive sections represent a total depth of ~220 μm for the series of sections shown in Fig. 5D. This agrees 
with the size of the spheroid measured after processing (Fig. 5B). Serial sections such as those shown in Fig. 5D are 
important for analyzing specific regions of a spheroid or to create 3D reconstructions.
Figure 5. Spheroid (HTB-126) processing effects and sectioning (A) Brightfield image of spheroid in PBS after 
fixation (B) Same spheroid after processing and embedding in a microarray in paraffin section. (C) Schematic of 
consecutive sections taken from a single spheroid using the coordinate system in Fig. 3G. (D) The cross-section 
of a single spheroid (stained with H&E) appearing on eleven consecutive 20 µm sections are digitally stitched 
together in a single image and labeled consecutively.
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Microarray sections. The ability to capture a certain percentage of embedded spheroids on a single slide using 
agarose microarray methods was analyzed quantitatively for 6 × 4 spheroid arrays, and qualitatively for a 12 × 8 
array. For quantitative analysis four 6 × 4 microarrays containing ~500 µm diameter (HTB-126) spheroids were 
sectioned and the total number of spheroids and their locations within the array were counted. Figure 6A shows 
eight 20 µm H&E stained sections taken from a single 6 × 4 array at zero magnification (note, two spheroids were 
purposely placed in well C4 to serve as a reference point to orient sections). Qualitatively, it may be noted that 22 
of 24 spheroids in the array appear on at least four of the sections and that some spheroids are more prominent 
at the beginning of the series, while others are more prominent at the end. The average percentage of sphe-
roids appearing on each of the five best consecutive sections (selected and counted as described in Supplemental 
Methods S.11) of each of four blocks (n = 4) was 79.2, 80.8, 86.7 & 90.0%, resulting in an overall average recovery 
of 20.2/24 + /−1.2 spheroids per section or 84.2% (total of 404 out of 480 possible: 4 blocks * 24 spheroids per 
block * 5 sections per block = 480). Figure 6B is a heat map that represents spheroid recovery based on initial 
location in the microarray. The numbers in Fig. 6B represent the total number of spheroids recovered from an 
individual location in the microarray on the best five sections from each of the four 6 × 4 spheroid blocks ana-
lyzed (maximum possible well score = 20, four blocks * five sections per block). The overall number of spheroids 
captured in each row, column, and individual well of the array was compiled to determine whether spheroid loss 
was more likely in areas such as the perimeter or corners of the microarray. ANOVA statistical analysis compar-
ing recapture rates between rows, columns, and individual wells did not identify any systematic loss of spheroids 
associated with different regions or wells. No single row (p = 0.48), column (p = 0.25) or well (p = 0.28) was 
found to be recaptured at a rate different than any other. As a proof of concept for using this method with much 
larger arrays, images of sections from 12 × 8 microarrays containing different types of spheroids and the metrics 
of spheroid recovery were compiled as shown in Fig. 6C,D and described in Supplemental Methods S.13. One 
array was constructed with breast cancer cell (HTB-126) spheroids with ~500 µm diameter. Two other arrays were 
constructed with myoblast cell (C2C12) spheroids with a disc shape ~500 µm in diameter and ~200 µm in height. 
The average number of spheroids appearing (minimum cross-sectional area >25% of center cut) on the 5 best 
slides for each block ranged from 62.9 to 86.3%.
Figure 6. Microarray sections and analysis. (A) Eight 20 µm serial sections taken from a 6 × 4 spheroid 
array (ordered 10, 9, 8, 7, 5, 3, 2, 1; from top left to bottom right; sections 4 & 6 were broken or folded during 
processing and unusable) from a 24-spheroid microarray. (B) Heat map containing number of times a spheroid 
was recaptured from a respective well in the 5 best sections of four different 24-spheroid microarrays (max 
possible = 20). (C) One section from each of three different 96-spheroid arrays are shown respectively from (top 
left to bottom right): HTB-126 stained with H&E, C2C12(block 1) unstained section with agarose pillars visible, 
C2C12(block 1) stained with H&E, C2C12(block 2) stained with H&E. (D) The table describes each of three 96 
spheroid array (12 × 8) blocks and the subsequent sectioned slides. Recovery rate is the number of spheroids 
appearing on a single slide.
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Discussion
Three-dimensional spheroid models have been established as a superior biological representation of in vivo tum-
ors compared to traditional 2D methods. Thus, tumor spheroid models become a valuable tool for studying 
cancer biology and screening drugs. These developments have led to increased research efforts as well as the 
formation of several companies that market lab wares for high throughput 3D culture. However, these systems 
are generally only assessable to colorimetric outputs for viability/proliferation and there are no available methods 
for detailed biomarker staining of spheroids in high throughput. This limitation becomes increasingly important 
as more complex anticancer drugs are developed that target specific pathways (other than cell death) to control 
cancer progression and metastasis15–18. Agarose spheroid microarray approaches make sectioning/staining pro-
cedures assessable to 3D tumor models by increasing throughput by ~96 times. Previous studies have shown that 
agarose embedding does not disrupt biomarker staining19–22. This increase in efficiency leads directly to major 
reductions in time and cost of labor and reagents for studies. Thus, with the help of this tool, researchers can 
conduct previously unreasonable 3D tumor model studies with more groups, time points, treatment groups, and 
replicates or extend the technology to personalized medicine approaches. Furthermore, staining comparison 
between samples within the same microarray slide will be more consistent because all samples are processed, 
stained, and imaged in parallel. Researchers will also be able to retrieve spatial localization of biomarker distribu-
tion to investigate regional effects associated with drug and nutrient diffusion and hypoxic effects.
The benefits of spheroid microarray embedding/sectioning include
•	 Increased throughput up to 96 spheroids in one block
•	 More consistent staining comparison between samples on the same slide
•	 Spatial localization of biomarker distribution
The goal of this manuscript is to disseminate this tool to researchers around the world to encourage them to 
conduct high throughput experiments with 3D tumor models at an expansive level that is not currently feasible. 
We expected that the method is quite transferable because several operators with limited histology experience 
were trained in the technique and generally could perform it with limited repetition. Three methods to manufac-
ture the negative molds are described to adapt to specific laboratory’s resources, approaches and goals. Fabrication 
of the microarray mold using an aluminum positive pre-mold has advantages including a single step procedure 
to make molds, and limited variation between PDMS molds; however, this method involved a more expensive/
difficult machining process and presents limitations in array hole-to-hole spacing due to required tooling for 
fabrication of the positive aluminum pre-mold. Fabrication using the plastic negative mold or agarose pre-mold 
process is more accessible and requires less skill and programming to manufacture, allowing many different 
geometric designs to be tested more rapidly. This method also allows for closer hole placement as it lacks the need 
to account for tooling clearance. The agarose pre-mold method comes at the cost of potential variability between 
PDMS molds, and the additional agarose step may introduce leveling issues as the material readily swells and 
shrinks depending on environmental conditions. One of the most important aspects of this agarose microarray 
embedding method when compared to other approaches19,20 is the fixation of the array directly to the cassette 
base in the same plane as the base (Fig. 3E,F, Supplemental Video 1). This allows the array to be easily aligned to 
the sectioning plane by aligning the mounting head of the microtome to the blade. Another advantage is that the 
spheroids are embedded at the very top of the agarose pillars. It is very easy to visualize agarose pillars on freshly 
cut sections (Fig. 6C) and thus easy to determine when the agarose pillars first enter the sectioning plane. By 
extension, the operator can easily determine when they have first reached the spheroid microarray that is posi-
tioned at the top of the agarose pillars. This approach resulted in extraordinary repeatability when considering the 
small margin of allowable error for microarray-to-cutting plane alignment (Fig. 4).
The results presented demonstrate the utility of the method by demonstrating multiple (5) histological slides 
containing more than 85% of initially embedded spheroids in a single slide, including a large 96 spheroid array. 
Other attempts to section a 96 spheroids array contained less embedded spheroids on a single slide (64%), possi-
bly because the height of these spheroids was smaller or because the HTB-126 and C2C12 spheroid array analysis 
experiments were performed by different researchers at different time periods. Even if multiple sections must be 
stained and imaged to capture all 96 spheroid that make up an array, there is still a significant time savings com-
pared to single spheroid embedding/sectioning. Further, since so many samples can be processed simultaneously, 
some complete sample loss can be accounted for by adding additional replicates. However, we do predict that the 
process can be further optimized to approach 100% spheroid recovery on several consecutive slides. Design con-
siderations for optimization would include pre-mold fabrication, agarose type, concentration & temperature; pil-
lar height, diameter & shape; dehydration & paraffin infiltration processes; sectioning and mounting techniques; 
and additional methodology considerations (described in detail in Supplemental Methods S.14). Efficiency of the 
technique could also be greatly improved with a method of automated spheroid placement from culture location 
directly into appropriate wells of the microarray.
The spheroid microarray technique described facilitates parallel analysis of up to 96 spheroids from a single 
paraffin block. The technique is simple to implement with tools available to most laboratories. Parallel analysis 
will make it more feasible for researchers using spheroid models to conduct detailed experiments that require 
biomarker staining outputs. With access to biomarker staining, researchers will be able perform more compre-
hensive 3D in vitro spheroid studies. These studies will require less cost, time and reagent, making it possible to 
run experiments with more cellular conditions, treatment types, doses, time points, and replicates. Importantly, 
immunohistochemical staining can be performed to yield numerous biomarker outputs with spatial localiza-
tion and double staining capability. In addition, quantitative comparison of staining intensity between samples 
within a microarray will be more reliable because all samples are processed, stained, and imaged in parallel. These 
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capabilities and reduced costs will help researchers to advance our understanding of tumor biology and facilitate 
advanced screening of tumor response to new experimental treatments or personalized medicine approaches. 
Spheroid microarray approach will also be valuable in applications including developmental biology, drug toxic-
ity, tissue engineering and organ on a chip.
Data availability
All data described in this manuscript and all details of methods described will be made readily available upon 
requests made to the corresponding author.
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